BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4088953)

  • 1. Grading of prostatic cancer: II. The prognostic significance of the presence of multiple architectural patterns.
    Schroeder FH; Blom JH; Hop WC; Mostofi FK
    Prostate; 1985; 6(4):403-15. PubMed ID: 4088953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of prostatic cancer (I): An analysis of the prognostic significance of single characteristics.
    Schroeder FH; Blom JH; Hop WC; Mostofi FK
    Prostate; 1985; 6(1):81-100. PubMed ID: 3969374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading of prostatic cancer: III. Multivariate analysis of prognostic parameters.
    Schroeder FH; Hop WC; Blom JH; Mostofi FK
    Prostate; 1985; 7(1):13-20. PubMed ID: 4080650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological evaluation of prostatic cancer. (II): Reproducibility of a histological grading system.
    Svanholm H; Starklint H; Barlebo H; Olsen S
    APMIS; 1990 Mar; 98(3):229-36. PubMed ID: 2317346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and outcome of nuclear anaplasia and mitotic index in prostatic adenocarcinomas.
    Kır G; Sarbay BC; Gumus E
    Urol Oncol; 2016 Oct; 34(10):430.e9-430.e16. PubMed ID: 27264167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined histologic grading of prostatic carcinoma.
    Böcking A; Kiehn J; Heinzel-Wach M
    Cancer; 1982 Jul; 50(2):288-94. PubMed ID: 7083133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
    McKenney JK; Wei W; Hawley S; Auman H; Newcomb LF; Boyer HD; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Tretiakova MS; Vakar-Lopez F; Carroll PR; Cooperberg MR; Gleave ME; Lance RS; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; Brooks JD
    Am J Surg Pathol; 2016 Nov; 40(11):1439-1456. PubMed ID: 27635949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic grading of prostatic carcinoma.
    Böcking A; Sinagowitz E
    Pathol Res Pract; 1980; 168(1-3):115-25. PubMed ID: 7433250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.
    Dong F; Yang P; Wang C; Wu S; Xiao Y; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2013 Dec; 37(12):1855-61. PubMed ID: 24145642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of prostatic carcinoma grading according to Helpap].
    Mahlke U; Ulman A; Kunz J
    Verh Dtsch Ges Pathol; 1993; 77():82-5. PubMed ID: 7511308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear shape and prognosis following orchiectomy in stage D2 prostate cancer.
    Miller J; Horsfall DJ; Skinner JM; Rao DM; Leong AS; Marshall VR
    Prostate; 1994 Jun; 24(6):306-12. PubMed ID: 7516069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of nuclear roundness as a tool for prostatic carcinoma grading].
    López A; Vilches J; Alvarez-Ossorio J; Aparicio J; Ronco A; Castiñeiras J
    Actas Urol Esp; 1992 Sep; 16(8):620-6. PubMed ID: 1462810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
    Fujikawa K; Sasaki M; Arai Y; Yamabe H; Ogawa O; Yoshida O
    Clin Cancer Res; 1997 Apr; 3(4):613-8. PubMed ID: 9815728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer.
    Blom JH; Ten Kate FJ; Schroeder FH; van der Heul RO
    Urol Res; 1990; 18(2):93-9. PubMed ID: 2187298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.
    Siadat F; Sykes J; Zlotta AR; Aldaoud N; Egawa S; Pushkar D; Kuk C; Bristow RG; Montironi R; van der Kwast T
    Prostate; 2015 Sep; 75(12):1277-84. PubMed ID: 25963383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of cytology in terms of survival in prostatic cancer].
    Valle Gerhold J; Azúa Blanco J; Gómez Aracil V; Villarroya Rodríguez S; Romeo Casabona P
    Actas Urol Esp; 1996 Apr; 20(4):330-5. PubMed ID: 8801793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.
    Diamond DA; Berry SJ; Umbricht C; Jewett HJ; Coffey DS
    Prostate; 1982; 3(4):321-32. PubMed ID: 7122329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.